United States Sorafenib Market Report 2016

United States Sorafenib Market Report 2016

1 Sorafenib Overview

1.1 Product Overview and Scope of Sorafenib

1.2 Classification of Sorafenib

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Sorafenib

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 USA Market Size Sales (Value) and Revenue (Volume) of Sorafenib (2011-2021)

1.4.1 USA Sorafenib Sales and Growth Rate (2011-2021)

1.4.2 USA Sorafenib Revenue and Growth Rate (2011-2021)

2 USA Sorafenib Competition by Manufacturers

2.1 USA Sorafenib Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Sorafenib Revenue and Share by Manufactures (2015 and 2016)

2.3 USA Sorafenib Average Price by Manufactures (2015 and 2016)

2.4 Sorafenib Market Competitive Situation and Trends

2.4.1 Sorafenib Market Concentration Rate

2.4.2 Sorafenib Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 USA Sorafenib Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 USA Sorafenib Sales and Market Share by Type (2011-2016)

3.2 USA Sorafenib Revenue and Market Share by Type (2011-2016)

3.3 USA Sorafenib Price by Type (2011-2016)

3.4 USA Sorafenib Sales Growth Rate by Type (2011-2016)

4 USA Sorafenib Sales (Volume) by Application (2011-2016)

4.1 USA Sorafenib Sales and Market Share by Application (2011-2016)

4.2 USA Sorafenib Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 USA Sorafenib Manufacturers Profiles/Analysis

5.1 Pfizer

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Sorafenib Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Allergan

5.2.2 Sorafenib Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Alnylam Pharmaceuticals

5.3.2 Sorafenib Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Amgen

5.4.2 Sorafenib Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Angstrom Pharmaceuticals

5.5.2 Sorafenib Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Acceleron Pharma

5.6.2 Sorafenib Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Biocon

5.7.2 Sorafenib Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Bionomics

5.8.2 Sorafenib Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 CASI Pharmaceuticals

5.9.2 Sorafenib Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Celgene Corporation

5.10.2 Sorafenib Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Enzon Pharmaceuticals

5.12 Five Prime Therapeutics

5.13 Fujifilm Kyowa Kirin Biologics

5.14 Genentech

5.15 Genexine

5.16 Hetero Drugs

5.17 ImClone Systems

5.18 Intas Pharmaceuticals

5.19 Kyowa Hakko Kirin

5.20 Levolta Pharmaceuticals

5.21 Mabtech

5.22 Marsala Biotech

5.23 Neumedicines

5.24 Novartis

5.25 Oncobiologics

5.26 Onyx Pharmaceuticals

6 Sorafenib Manufacturing Cost Analysis

6.1 Sorafenib Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Sorafenib

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Sorafenib Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 USA Sorafenib Market Forecast (2016-2021)

10.1 USA Sorafenib Sales, Revenue Forecast (2016-2021)

10.2 USA Sorafenib Sales Forecast by Type (2016-2021)

10.3 USA Sorafenib Sales Forecast by Application (2016-2021)

10.4 Sorafenib Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Sorafenib

Table Classification of Sorafenib

Figure USA Sales Market Share of Sorafenib by Type in 2015

Table Application of Sorafenib

Figure USA Sales Market Share of Sorafenib by Application in 2015

Figure USA Sorafenib Sales and Growth Rate (2011-2021)

Figure USA Sorafenib Revenue and Growth Rate (2011-2021)

Table USA Sorafenib Sales of Key Manufacturers (2015 and 2016)

Table USA Sorafenib Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Sorafenib Sales Share by Manufacturers

Figure 2016 Sorafenib Sales Share by Manufacturers

Table USA Sorafenib Revenue by Manufacturers (2015 and 2016)

Table USA Sorafenib Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Sorafenib Revenue Share by Manufacturers

Table 2016 USA Sorafenib Revenue Share by Manufacturers

Table USA Market Sorafenib Average Price of Key Manufacturers (2015 and 2016)

Figure USA Market Sorafenib Average Price of Key Manufacturers in 2015

Figure Sorafenib Market Share of Top 3 Manufacturers

Figure Sorafenib Market Share of Top 5 Manufacturers

Table USA Sorafenib Sales by Type (2011-2016)

Table USA Sorafenib Sales Share by Type (2011-2016)

Figure USA Sorafenib Sales Market Share by Type in 2015

Table USA Sorafenib Revenue and Market Share by Type (2011-2016)

Table USA Sorafenib Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Sorafenib by Type (2011-2016)

Table USA Sorafenib Price by Type (2011-2016)

Figure USA Sorafenib Sales Growth Rate by Type (2011-2016)

Table USA Sorafenib Sales by Application (2011-2016)

Table USA Sorafenib Sales Market Share by Application (2011-2016)

Figure USA Sorafenib Sales Market Share by Application in 2015

Table USA Sorafenib Sales Growth Rate by Application (2011-2016)

Figure USA Sorafenib Sales Growth Rate by Application (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Sorafenib Sales Market Share (2011-2016)

Table Allergan Basic Information List

Table Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Allergan Sorafenib Sales Market Share (2011-2016)

Table Alnylam Pharmaceuticals Basic Information List

Table Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alnylam Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Sorafenib Sales Market Share (2011-2016)

Table Angstrom Pharmaceuticals Basic Information List

Table Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Angstrom Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Acceleron Pharma Basic Information List

Table Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Acceleron Pharma Sorafenib Sales Market Share (2011-2016)

Table Biocon Basic Information List

Table Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Biocon Sorafenib Sales Market Share (2011-2016)

Table Bionomics Basic Information List

Table Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bionomics Sorafenib Sales Market Share (2011-2016)

Table CASI Pharmaceuticals Basic Information List

Table CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table CASI Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Celgene Corporation Basic Information List

Table Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Celgene Corporation Sorafenib Sales Market Share (2011-2016)

Table Enzon Pharmaceuticals Basic Information List

Table Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Enzon Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Five Prime Therapeutics Basic Information List

Table Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Five Prime Therapeutics Sorafenib Sales Market Share (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Basic Information List

Table Fujifilm Kyowa Kirin Biologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Fujifilm Kyowa Kirin Biologics Sorafenib Sales Market Share (2011-2016)

Table Genentech Basic Information List

Table Genentech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genentech Sorafenib Sales Market Share (2011-2016)

Table Genexine Basic Information List

Table Genexine Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Genexine Sorafenib Sales Market Share (2011-2016)

Table Hetero Drugs Basic Information List

Table Hetero Drugs Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hetero Drugs Sorafenib Sales Market Share (2011-2016)

Table ImClone Systems Basic Information List

Table ImClone Systems Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table ImClone Systems Sorafenib Sales Market Share (2011-2016)

Table Intas Pharmaceuticals Basic Information List

Table Intas Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Intas Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Kyowa Hakko Kirin Basic Information List

Table Kyowa Hakko Kirin Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kyowa Hakko Kirin Sorafenib Sales Market Share (2011-2016)

Table Levolta Pharmaceuticals Basic Information List

Table Levolta Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Levolta Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Mabtech Basic Information List

Table Mabtech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Mabtech Sorafenib Sales Market Share (2011-2016)

Table Marsala Biotech Basic Information List

Table Marsala Biotech Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Marsala Biotech Sorafenib Sales Market Share (2011-2016)

Table Neumedicines Basic Information List

Table Neumedicines Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Neumedicines Sorafenib Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Sorafenib Sales Market Share (2011-2016)

Table Oncobiologics Basic Information List

Table Oncobiologics Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oncobiologics Sorafenib Sales Market Share (2011-2016)

Table Onyx Pharmaceuticals Basic Information List

Table Onyx Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2011-2016)

Table Onyx Pharmaceuticals Sorafenib Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Sorafenib

Figure Manufacturing Process Analysis of Sorafenib

Figure Sorafenib Industrial Chain Analysis

Table Raw Materials Sources of Sorafenib Major Manufacturers in 2015

Table Major Buyers of Sorafenib

Table Distributors/Traders List

Figure USA Sorafenib Production and Growth Rate Forecast (2016-2021)

Figure USA Sorafenib Revenue and Growth Rate Forecast (2016-2021)

Table USA Sorafenib Production Forecast by Type (2016-2021)

Table USA Sorafenib Consumption Forecast by Application (2016-2021)